<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell J</journal-id><journal-id journal-id-type="iso-abbrev">Cell J</journal-id><journal-id journal-id-type="publisher-id">Royan Institute</journal-id><journal-title-group><journal-title>Cell Journal (Yakhteh)</journal-title></journal-title-group><issn pub-type="ppub">2228-5806</issn><issn pub-type="epub">2228-5814</issn><publisher><publisher-name>Royan Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">36043404</article-id><article-id pub-id-type="pmc">PMC9428477</article-id><article-id pub-id-type="other">Cell-J-24-364</article-id><article-id pub-id-type="doi">10.22074/cellj.2022.7922</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject><subj-group><subject>Biophysics</subject><subject>Cellular and Molecular Biology</subject></subj-group></subj-group></article-categories><title-group><article-title>Extremely Low Frequency Magnetic Fields Induce <italic>mTOR</italic> and
<italic>Hsa_Circ_100338</italic> Expression Changes in Gastric Cancer
and Normal Fibroblast Cell Lines </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mansoury</surname><given-names>Fereshteh</given-names></name><degrees>Ph.D</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Babaei</surname><given-names>Nahid</given-names></name><degrees>Ph.D</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Abdi</surname><given-names>Soheila</given-names></name><degrees>Ph.D</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Entezari</surname><given-names>Maliheh</given-names></name><degrees>Ph.D</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Doosti</surname><given-names>Abbas</given-names></name><degrees>Ph.D</degrees><xref rid="A5" ref-type="aff">5</xref></contrib><aff id="A1"><label>1</label>Department of Cell Biology and Genetics, Bushehr Branch, Islamic Azad University, Bushehr, Iran</aff><aff id="A2"><label>2</label>Department of Physics, Safadasht Branch, Islamic Azad University, Tehran, Iran</aff><aff id="A3"><label>3</label>Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences Branch, Islamic Azad University,
Tehran, Iran</aff><aff id="A4"><label>4</label>Farhikhtegan Medical Convergence, Science Research Center, Farhikhtegan Hospital, Tehran Medical Sciences, Islamic Azad
University, Tehran, Iran</aff><aff id="A5"><label>5</label>Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran</aff></contrib-group><author-notes><corresp id="cor1">
<label>* Corresponding Address:</label>
<addr-line>P.O.Box: 3164348658</addr-line>
<addr-line>Department of Physics</addr-line>
<addr-line>Safadasht Branch</addr-line>
<institution>Islamic Azad University</institution>
<addr-line>Tehran</addr-line><country>Iran</country>
Email: <email>soheilaabdi@safaiau.ac.ir</email>
</corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>27</day><month>7</month><year>2022</year></pub-date><volume>24</volume><issue>7</issue><fpage>364</fpage><lpage>369</lpage><history><date date-type="received"><day>29</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>24</day><month>5</month><year>2021</year></date></history><permissions><copyright-statement>Any use, distribution, reproduction or abstract of this publication in any medium,
with the exception of commercial purposes, is permitted provided the original work is properly cited.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial 3.0 (CC BY-NC 3.0) License, which permits
unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original
work is properly cited. </license-p></license></permissions><abstract><sec><title>Objective</title><p> Extremely low-frequency magnetic field (ELF-MF) exposure, as a targeted tumor therapy, presents several
potential advantages. In this research, we investigated effects of different ELF-MF intensities on cell viability and
expression levels of the mammalian target of rapamycin (mTOR) and hsa_circ_100338 in the normal fibroblast (Hu02)
and human gastric adenocarcinoma (AGS) cell lines.
</p></sec><sec><title>Materials and Methods</title><p>In this experimental study, cell lines of AGS and Hu02, were cultured under the exposure of ELF-
MF with magnetic flux densities (MFDs) of 0.25, 0.5, 1 and 2 millitesla (mT) for 18 hours. The 3-(4, 5-dimethylthiazoyl-2-
yl)-2, 5-diphenyltetrazolium bromide (MTT) assay was used to evaluate the cell viability. Relative expression of mTOR
and hsa_circ_100338 RNAs was estimated by quantitative real-time polymerase chain reaction (qRT-PCR) technique.</p></sec><sec><title>Results</title><p> Viability of the normal cells was significantly increased at MFDs of 0.5, 1 and 2 mT, while viability of the
tumor cells was significantly decreased at MFD of 0.25 and increased at MFD of 2 mT. Expression level of mTOR was
significantly increased at the all applied MFDs in the normal cells, while it was significantly decreased at MFDs of 0.25
and 0.5mT in the tumor cells. MFDs of 1 and 2 mT in tumor cells inversely led to the increase in mTOR expression.
hsa_circ_100338 was downregulated in MFD of 0.25 mT and then it was increased parallel to the increase of MFD in
the normal and tumor cells.
</p></sec><sec><title>Conclusion</title><p>Results of the present study indicated that ELF-MF at MFDs of 0.25 and 0.5 mT can lead to decrease
in the both mTOR and hsa_circ_100338 expression levels. Given the role of mTOR in cell growth, proliferation and
differentiation, in addition to the potential role of hsa_circ_100338 in metastasis, expression inhibition of these two
genes could be a therapeutic target in cancer treatment.</p></sec></abstract><kwd-group><kwd>Circulating MicroRNA</kwd><kwd>Gastric Cancer</kwd><kwd>Gene Expression</kwd><kwd>Magnetic Field</kwd><kwd>mTOR Protein</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>Citation</meta-name><meta-value>Mansoury F, Babaei N, Abdi S, Entezari M, Doosti A. Extremely low frequency magnetic fields induce mTOR and Hsa_Circ_100338 expression
changes in gastric cancer and normal fibroblast cell lines. Cell J. 2022; 24(7): 364-369. doi: 10.22074/cellj.2022.7922.
This open-access article has been published under the terms of the Creative Commons Attribution Non-Commercial 3.0 (CC BY-NC 3.0).</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Today, due to the increasing presence of
electromagnetic fields in daily life, its effects on health
have received much attention. It has been found that
magnetic fields can affect living systems, but their
beneficial or harmful effects have not been fully
investigated (<xref rid="B1" ref-type="bibr">1</xref>). Association of electromagnetic fields
with risk of various cancers, including postmenopausal
breast cancer (<xref rid="B2" ref-type="bibr">2</xref>), childhood leukemia (<xref rid="B3" ref-type="bibr">3</xref>) and lung
cancer (<xref rid="B4" ref-type="bibr">4</xref>) has been demonstrated by some studies.
It has been found that electromagnetic fields affects
a variety of physiological processes (<xref rid="B5" ref-type="bibr">5</xref>), while such
effects depend on extremely low-frequency magnetic
field (ELF-MF) frequency and duration (<xref rid="B6" ref-type="bibr">6</xref>).</p><p>Plasma membrane structure, intracellular signal
transduction pathways and gene transcription could
be changed following the exposure of electromagnetic
fields (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>).</p><p>Applying the electromagnetic field as a non-invasive
technique was used in the oncology field to treat cancer
cells. In EMF therapy micro-currents are exposed locally
to the specific tissue or the entire body. ELF-MF is used
for the treatment of several diseases like Parkinson disease
(<xref rid="B9" ref-type="bibr">9</xref>). EMF therapy, in the wave range of 0-300 Hz can help
reduce dosage, harmful side-effects of chemotherapy
and radiotherapy, further to enhancing prognosis of the
disease (<xref rid="B10" ref-type="bibr">10</xref>).</p><p>During the last few years, the mammalian target of rapamycin (<italic>mTOR</italic>) has
received significant attention for its importance in treating cancer. <italic>mTOR</italic>
plays an important role in cancer cell growth through affecting the activity of elF4F
complex. This enzyme increases translation by phosphorylating two targets of ribosomal p70S6
kinase (S6K1) and initiation factor 4E binding protein 1 (4E-BP1) (<xref rid="B11" ref-type="bibr">11</xref>). Stimulating
expression of the membrane surface carriers is one of the most important roles of
<italic>mTOR</italic> in the body, leading to the increase access to nutrients for cell
growth and proliferation (<xref rid="B12" ref-type="bibr">12</xref>). Moreover, <italic>mTOR</italic> also enhances expression of
hypoxia-inducible factor-1&#x003b1; (HIF1&#x003b1;), which plays a key role in angiogenesis. Therefore,
mutations in the upstream components of the <italic>mTOR</italic> pathway are implicated in
cancer progression (<xref rid="B13" ref-type="bibr">13</xref>). Some studies indicated that <italic>mTOR</italic> dysfunction is
applied as a therapeutic target in gastric cancer (GC). Additionally, increased
<italic>mTOR</italic> activity is directly related to tumor progression and low patient
survival (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>Circular RNAs (circRNAs) are non-coding RNAs with stable structure and tissue-specific
expression (<xref rid="B15" ref-type="bibr">15</xref>). Unlike other RNAs, circRNAs are resistant to degradation and they are
highly ubiquitous in the transcriptome of eukaryotes (<xref rid="B16" ref-type="bibr">16</xref>). Some studies have shown that
circRNAs can act as microRNA (miRNA) sponges, regulators of splicing and transcription, as
well as altering gene expression (<xref rid="B15" ref-type="bibr">15</xref>). Changes in circRNA expression could induce abnormal
cellular functions and various diseases including cardiovascular diseases and various
cancers (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). A recent study showed the clinical significance of
<italic>hsa_circRNA_100338 </italic>in hepatocellular carcinoma (HCC) and suggested that
this circRNA could be a potential biomarker for HCC. The report also revealed that
<italic>hsa_circRNA_100338 </italic>could act as a sponge for miR-141-3p and increase
potential of the liver cancer cells to metastases (<xref rid="B19" ref-type="bibr">19</xref>). Although some studies were done to
provide <italic>hsa_circRNA_100338 </italic>as a biomarker of cancer cells, there is no
evidence to assay the expression level of <italic>hsa_circRNA_100338 </italic>on GC cells at
different electromagnetic flux densities.</p><p>The aim of this study was to investigate effect of magnetic flux densities (MFDs) of 0.25,
0.5, 1 and 2 millitesla (mT) on the expression level of <italic>mTOR</italic> and
<italic>hsa_circRNA_100338 </italic>in a human gastric cancer cell line (AGS) and human
normal fibroblast (Hu02) cells after 18 hours.</p></sec><sec sec-type="materials-methods"><title>Materials and Methods</title><p>In this experimental research, expression levels of <italic>mTOR</italic> and
<italic>hsa_circ_100338</italic> were determined in AGS cell line, as tumor cell and Hu02
cell line, as normal cells, following the exposure to MFDs of 0.25, 0.5, 1 and 2 mT in
comparison to the unexposed cells.</p><p>This study was approved by the Ethics Committee of
Bushehr University of Medical Sciences (IR.BPUMS.
REC.1339.180).</p><sec><title>Cell culture </title><p>Human gastric adenocarcinoma (AGS) and human
normal fibroblast (Hu02) cell lines were purchased from
the National Genetic Resources Center of Iran, and then
according to their instructions, the cells were seeded
monolayer in the 25 ml flasks. AGS cells were cultured
in Ham&#x02019;s F12 (Gibco, USA) medium as described in the
previous study (<xref rid="B20" ref-type="bibr">20</xref>). The cells were exposed to ELF-MF
with MFDs of 0.25, 0.5, 1 and 2 mT continuously for 18
hours.</p></sec><sec><title>Exposure system</title><p>Electromagnetic fields were produced by the system consisted of a solenoid cylinder of
diameter 12 cm, length 30 cm and 1200 turns (<xref rid="B21" ref-type="bibr">21</xref>). To produce various electromagnetic
intensities with a frequency of 50 Hz, an alternative current power supply (TDGC2, 220v,
50- 60 Hz; Delta International Electric, China) was applied. The electromagnetic field
generated inside the solenoid is uniform and in the direction of the cylindrical axis. The
solenoid cylinder was placed horizontally at the center of the CO<sub>2</sub> incubator
and flasks of cells were placed in the middle of the cylinder. The sham groups were
incubated at the same condition inside the solenoid cylinder, while the circuit was
interrupted. A digital teslameter with a 3&#x02010;D sensor (Holaday, USA) was used to estimate
the electromagnetic flux density at the middle of the solenoid cylinder.</p></sec><sec><title>MTT assay</title><p>The cell viability was determined by the 3-(<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>-dimethylthiazoyl-2-yl)-2,
5-diphenyltetrazolium bromide (MTT) assay. For this purpose, the medium was removed from
the cultured cells in the 96 well plates. Then, the MTT solution was added to each well
after which the plate was incubated for 4 hours at 37&#x000b0;C with 5% CO<sub>2</sub> . After
removing supernatant, 100 &#x003bc;l Dimethylsulfoxide (DMSO) was added to each well and shaken
well to dissolve all formazan crystals. Finally, the absorption was measured at 570 nm by
a microplate reader (Synegry HT, USA). </p></sec><sec><title>RNA extraction, cDNA synthesis and real-timepolymerase chain reaction</title><p>To measure expression changes of <italic>mTOR</italic> and
<italic>hsa_circRNA_100338</italic>, real-time PCR (qRT-PCR) was used. Briefly, total
RNA was extracted by using TRIzol reagent (TRI Sigma-Aldrich, Germany) according to the
manufacturer&#x02019;s instruction. Takara RNA PCR Kit was used to synthesize cDNA. Quantitative
real-time PCR (qRTPCR) was performed by Bioneer Exicycler&#x02122; 96 Detection System. Detail of
the PCR steps have been described in our previous studies (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B22" ref-type="bibr">22</xref>). The primer sequences
are listed in Table 1.</p><p>Delta threshold cycle value (&#x00394;Ct) was measured for each sample to determine the relative
expression of genes to the housekeeping gene and then the delta delta threshold cycle
value (&#x00394;&#x00394;Ct) which is the difference between &#x00394;Ct of the exposed tumor or normal cells and
control group was determined. Fold changes of gene and miRs expression was calculated by
2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> formula. </p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>The sequences of <italic>GAPDH, mTOR</italic>, and <italic>hsa _circ_100338</italic> primers used
in the current study</p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="2" rowspan="1">
<hr/>
</th></tr><tr><th rowspan="1" colspan="1">Genes</th><th rowspan="1" colspan="1">Primer sequences (5&#x02032;-3&#x02032;)</th></tr><tr><th colspan="2" rowspan="1">
<hr/>
</th></tr><tr><td align="left" rowspan="2" colspan="1">hsa_circ_100338</td><td rowspan="1" colspan="1">F: AAAAGCAAGCAGTGCCCATA</td></tr><tr><td rowspan="1" colspan="1">R: GCTCGAATCAGGTCCACCA</td></tr><tr><td align="left" rowspan="2" colspan="1">mTOR</td><td rowspan="1" colspan="1">F: AGCATCGGATGCTTAGGAGTGG </td></tr><tr><td rowspan="1" colspan="1">R: CAGCCAGTCATCTTTGGAGACC </td></tr><tr><td align="left" rowspan="2" colspan="1">GAPDH</td><td rowspan="1" colspan="1">F: GCACCGTCAAGGCTGAGAAC</td></tr><tr><td rowspan="1" colspan="1">R: GGATCTCGCTCCTGGAAGATG</td></tr><tr><th colspan="2" rowspan="1">
<hr/>
</th></tr></tbody></table></table-wrap></sec><sec><title>Statistical analysis</title><p>SPSS software version 25 was used to analysis the data.
The results were shown as mean &#x000b1; standard deviation
(mean &#x000b1; SD). To compare significant differences among
the groups, one-way and two-way analyses of variance
and Tukey Post hoc test were used. The level of probability
for the significant differences among the groups was
considered as P&#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Cell viability measurement</title><p>ELF-MF with MFD of 0.25 mT did not affect cell
viability of the normal cells while exposure to MFDs
of 0.5, 1 and 2 mT lead to a significant increase in cell
viability (P&#x0003c;0.0001).</p><p>Exposure of tumor cells to 0.25 mT MFD led to a
significant decrease in cell viability, but the cell viability
was increased in parallel with the increase of MFD and
this increase was significant at MFD of 2 mT (<xref rid="F1" ref-type="fig">Fig .1</xref>).
Sidak analysis showed a significant decrease in tumor
cells in comparison with normal cells in terms of viability
at MFDs of 0.25 (P=0.02), 0.5 (P&#x0003c;0.0001), 1 (P&#x0003c;0.0001),
and 2 mT (P&#x0003c;0.0001, <xref rid="F1" ref-type="fig">Fig .1</xref>).</p><fig position="float" id="F1"><label>Fig 1</label><caption><p>Mean viability percentage of the normal cells and tumor cells,
following the exposure to continuous MFDs of 0.25, 0.5, 1 and 2 mT for
18 hours in comparison to the unexposed cells. *; P&#x0003c;0.05, ***; P&#x0003c;0.001,
MFDs; Magnetic flux densities, and ns; Non significant. </p></caption><graphic xlink:href="Cell-J-24-364-g01" position="float"/></fig></sec><sec><title>Relative expression of <italic>mTOR</italic>
</title><p>Expression level of the <italic>mTOR</italic> gene in the normal cells exposed to
different intensities of ELF-MF was significantly higher than that of the unexposed normal
cells (P&#x0003c;0.001). The highest and lowest expression level of this gene was observed
at 2 mT and 0.5 mT respectively (<xref rid="F2" ref-type="fig">Fig .2A</xref>). However, pattern of <italic>mTOR</italic>
expression level in tumor cells was different from that in normal cells. By that means the
expression level of the gene in exposed tumor cells at MFDs of 0.25 mT and 0.5 mT was
downregulated and at MFDs of 1 and 2 mT was upregulated compared to unexposed tumor cells
(<xref rid="F2" ref-type="fig">Fig .2B</xref>). Expression level of the <italic>mTOR</italic> gene in the exposed and unexposed
tumor cells, as well as the exposed and unexposed normal cells, was analyzed using the
sidak test. As evident from the data shown in Figure 2C, the unexposed tumor cells showed
no significant difference compared to unexposed normal cells concerning the relative
expression of <italic>mTOR</italic> mRNA (P&#x0003e;0.05). However, relative expression of mTOR
mRNA was significantly downregulated in the exposed tumor cells at MFDs of 0.25
(P&#x0003c;0.0001, 0.03 FC), 0.5 (P&#x0003c;0.0001, 0.05 FC), 1 (P&#x0003c;0.0001, 0.38 FC)
and 2 (P=0.003, 0.68 FC) mT in comparison with the exposed normal cells (<xref rid="F2" ref-type="fig">Fig .2C</xref>).</p><fig position="float" id="F2"><label>Fig 2</label><caption><p>Comparison of <italic>mTOR</italic> expression levels in normal and tumor cells in different
MFDs. mRNA expression level of <italic>mTOR</italic> in the <bold>A.</bold> Exposed
normal and <bold>B. </bold>Gastric tumor cells at various MFDs. <bold>C.</bold>
Comparison of the mRNA expression level of <italic>mTOR</italic> in the exposed,
unexposed normal and tumor cells. Different letters on each column show statistically
significant difference, and the same letters on each column has no difference. ***;
P&#x0003c;0.001 and MFD; Magnetic flux densities.</p></caption><graphic xlink:href="Cell-J-24-364-g02" position="float"/></fig></sec><sec><title>Relative expression of <italic>hsa_circ_100338</italic></title><p>Expression level of <italic>hsa_circ_100338</italic> in the exposed normal cells
significantly down regulated at MFD of 0.25 mT (0.18 FC, P=0.0005) compared to the
unexposed normal cells. At the other intensities, no significant change was observed
(<xref rid="F3" ref-type="fig">Fig .3A</xref>). However, relative expression of <italic>mTOR</italic> mRNA was significantly
down-regulated in the exposed tumor cells at MFDs of 0.25 (0.002 FC, P&#x0003c;0.0001), 0.5
(0.013 FC, P&#x0003c;0.0001), 1 (0.19 FC, P=0.0016) and 2 mT (0.31 FC, P=0.017) in
comparison with the unexposed tumor cells (<xref rid="F3" ref-type="fig">Fig .3B</xref>). Sidak test was used to analyze
expression level of the <italic>hsa_circ _100338</italic> in the all groups of tumor and
normal cells. As shown in Figure 3C, the obtained data showed no significant difference
between the unexposed tumor cells and unexposed normal cells. Concerning the expression
level of <italic>has-circ-0005986</italic> (P&#x0003e;0.05). However, expression level of the
<italic>hsa _circ_100338</italic> was significantly increased in the exposed tumor cells
at MFDs of 0.25 (P&#x0003c;0.0001, 0.013 FC), 0.5 (0.024 FC, P&#x0003c;0.0001), 1 (0.16 FC,
P&#x0003c;0.0001) and 2 (0.22 FC, P&#x0003c;0.0001) mT.</p><fig position="float" id="F3"><label>Fig 3</label><caption><p>Comparison of <italic>hsa_circ_100338</italic> expression levels in normal and tumor cells in
different MFDs. Relative expression level of <italic>hsa_ circ_100338</italic> in the
<bold>A. </bold>Tumor and <bold>B.</bold> Normal cells with different MFDs.<bold> C.
</bold>Comparison of mRNA expression level of <italic>hsa_circ_100338</italic> in the
exposed and unexposed normal cells with tumor cells. Different letters on each column
show statistically significant differences, the columns having common letters show
statistically no significant difference. ***; P&#x0003c;0.001, ns; Non significant, and
MFDs; Magnetic flux densities.</p></caption><graphic xlink:href="Cell-J-24-364-g03" position="float"/></fig></sec><sec><title>Correlation analysis</title><p>A significant positive correlation (r=0.799, 95% CI=0.4866 to 0.9306, P=0.0003) was
observed between expression level of the <italic>hsa_circ_100338</italic> and
<italic>(mTOR) </italic>genes in the tumor cells exposed to extremely low frequency
magnetic fields (ELF-MF). As shown in Figure 4, no significant correlation was observed
between expression level of the <italic>hsa_circ_100338</italic> and mTOR genes in the
normal cells exposed to ELF-MF (P=0.540).</p><fig position="float" id="F4"><label>Fig 4</label><caption><p>Correlation analysis between <italic>mTOR</italic> and <italic>hsa_circ_100338</italic> gene
expressions in <bold>A.</bold> Normal cells and <bold>B. </bold>Gastric cancer cell
lines exposed to extremely low frequency magnetic fields (ELF-MF).</p></caption><graphic xlink:href="Cell-J-24-364-g04" position="float"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>In the present study, effects of ELF-MF with MFDs of 0.25, 0.5, 1; and 2mT on AGS and Hu02
cell lines were investigated. Our finding indicated that ELF-MF can affect the cell
viability and change the expression levels of <italic>mTOR</italic> and
<italic>hsa_circRNA_100338 </italic>in the both tumor and normal cells. Expression levels
of <italic>mTOR</italic> were significantly increased at all applied MFDs in the normal
cells while it was significantly decreased at MFDs of 0.25 and 0.5 mT in tumor cells. MFDs
of 1 and 2 mT in tumor cells inversely lead to the increase in <italic>mTOR</italic>
expression. <italic>Hsa_circ_100338</italic> was down-regulated in MFD of 0.25 mT and then
was increased parallel to the increase in MFD in normal and tumor cells. </p><p>Interaction of ELF-MF with living organisms could induce different biological effects that
depend on the type, MFD, frequency and time of exposure (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B23" ref-type="bibr">23</xref>). There are some studies that
indicated antitumor effect of EMFs (<xref rid="B24" ref-type="bibr">24</xref>). Release of intracellular proteases that alter the
integrity of cancer cell membrane was reported in A549 human lung cancer cells exposed to 50
and 385 Hz electromagnetic fields (<xref rid="B25" ref-type="bibr">25</xref>). Decreased growth of breast cancer tumor cells under
the influence of magnetic fields has been reported (<xref rid="B26" ref-type="bibr">26</xref>). These cytotoxic effects have been
attributed to changes in plasma membrane properties, impaired Ca<sup>+2</sup> penetration
(<xref rid="B27" ref-type="bibr">27</xref>) and changes in cytoskeletal structure (<xref rid="B28" ref-type="bibr">28</xref>). In the present study, cytotoxic effects of
the ELF-MF with MFD of 0.25 mT on gastric cancer cells were observed. However, some
conflicting researches have been reported in this regard. Some researchers reported inducing
effects of cell proliferation (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>) and the others demonstrated cytotoxic effects of EMFs
(<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>). Different results of magnetic fields in this study can be explained by EMFs window
effects hypothesis. The window effect is a biological response that only occurs at certain
criteria of the frequency, amplitude, intensity and time of exposure, while outside of these
criteria, the biological system does not respond to EMFs (<xref rid="B33" ref-type="bibr">33</xref>). The intensities of 0.5-2 mT
showed no decrease in cell viability of tumor cells but a relative increase in it, which
indicate the anti-apoptotic effects of ELF-MF (<xref rid="B34" ref-type="bibr">34</xref>). It was shown that ELF-MF protected
cancer cells from apoptosis due to heat shock (<xref rid="B35" ref-type="bibr">35</xref>). It was demonstrated that
<italic>PI3K/AKT/mTOR</italic> pathway activation in GC could impair cell growth and
proliferation as well as, metabolism and angiogenesis (<xref rid="B14" ref-type="bibr">14</xref>). In this study, it was shown that
<italic>mTOR</italic> gene was overexpressed in the GC cell lines at 2 mT ELF-MF, but at
MFDs of 0.25 and 0.5 mT, this gene was down-regulated in comparison with the unexposed GC
cell lines. Phosphorylation of Ser2448 <italic>mTOR</italic> enzyme activates eukaryotic
initiation factor 4E (elF4E) and ribosomal S6 kinase p70 (p70S6 kinase 1) and inactivates
eIF4E inhibitor 4E-BO.1. In other words, overexpression of the <italic>mTOR</italic> gene
upregulated expression level of cell growth and cell division mediators including cyclin D1,
and down-regulated expression level of cell cycle progression regulators (<xref rid="B36" ref-type="bibr">36</xref>). Therefore,
MFDs of 0.25 and 0.5 mT, which caused a sharp decrease in <italic>mTOR</italic> expression
level of GC cell lines, can be considered as a treatment for gastric cancer. </p><p>Moreover, according to the results, expression level of <italic>hsa_circ_100338</italic> in
AGS cell lines showed significant differences at different MFDs and this led to the
downregulation of <italic>hsa_circ_100338 </italic>expression level in an
intensity-dependent manner. So that, the lowest expression level of
<italic>hsa_circ_100338</italic> was seen at 0.25 mT ELF-MF. Nevertheless, by increasing,
MFD of the electromagnetic field, its expression level was also increased. Few studies have
been performed to determine the role of circRNAs in cancer. Our results suggested that
<italic>hsa_circ_100338 </italic>could be a good biomarker for diagnosis of gastric
cancer. The biomarker role of <italic>hsa_circ_100338</italic> has been reported in HCC. It
has been shown that <italic>hsa_circ_100338</italic> acted as a miR-141-3p sponge in HCC
tissue (<xref rid="B19" ref-type="bibr">19</xref>). The other study revealed that circRNA-100338 was involved in regulation of
angiogenesis and HCC metastasis (<xref rid="B37" ref-type="bibr">37</xref>). In the current study, therefore,
<italic>hsa_circ_100338</italic> in AGS cells may also interact with miRNAs.
Downregulation of <italic>hsa_circ_100338</italic> expression level was observed in AGS
cells exposed to MFD of 0.25 mT. </p><p><italic>Hsa_circ_100338 </italic>expression level had positive correlation with
<italic>mTOR</italic> in the tumor cells following exposure of ELF-MF, whereas the normal
cells treatment with ELF-MF showed no significant correlation. A study showed that
<italic>hsa_circ_100338</italic> regulated protein kinase activity of
<italic>mTOR</italic> in HCC patients and operated as a key regulator in promoting the
<italic>mTOR</italic> signaling pathway. The study indicated that not only gene expression
level of <italic>hsa_ circ_100338</italic> was increased in HCC cells compared to the normal
cells, but also knockdown of <italic>hsa_circ_100338</italic> gene affected cell
proliferation ability (<xref rid="B37" ref-type="bibr">37</xref>).</p><p>ELF-EMFs can alter gene expression by several mechanisms, including alteration of cell
membrane channels like calcium channels (<xref rid="B38" ref-type="bibr">38</xref>), increase in free radicals formation and
stability (<xref rid="B39" ref-type="bibr">39</xref>), in addition to direct interaction with DNA (<xref rid="B40" ref-type="bibr">40</xref>). Overall, decrease of
<italic>mTOR</italic> and <italic>hsa_circ_100338</italic> expressions as well as cell
viability decrease in tumor cells, following the exposure to MFD of 0.25 mT in this study,
indicated that this MFD had the most beneficial effects and it can be considered as an
adjutant therapeutic method in cancer treatment.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Results of the present study indicated that ELF-MF at MFDs of 0.25 and 0.5 mT can
down-regulated both <italic>mTOR</italic> and <italic>hsa_circ_100338</italic> expressions.
Given the role of <italic>mTOR</italic> in cell growth, proliferation, differentiation and
the potential role of <italic>hsa_circ_100338</italic> in metastasis, the expression
inhibition of these two genes could be a therapeutic target in cancer treatment. However,
more in vitro and <italic>in vivo</italic> researches are needed to find suitable MFD and
exposure protocols to suppress and control cancer cell with fewer side-effects. </p></sec></body><back><ack><title>Acknowledgements</title><p>This research project was approved by the Bushehr
Branch of Islamic Azad University with the code number
1464865796403321398120546. The authors would like
to thank Ms. Hadiseh Mohammadpour and Ms. Neda
Tekiyemaroof, from Cancer Institute, Tehran University
of Medical Sciences and Razi Drug Research Center of
Iran University of Medical Sciences (Tehran, Iran). There
is no conflict of interest in this study.</p></ack><bio id="d64e655"><title>Authors&#x02019; Contributions</title><p>S.A.; Was the designer of the project and responsible for
overall supervision. N.B.; Was involved in experimental
studies and data analysis. F.M.; Carried out all
experimental works, including primer design, cell culture, qRT-PCR, and data analysis. M.E., A.D.; Were involved
in experimental studies and drafting the manuscript. The
authors have read and approved the final manuscript.</p></bio><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abdi</surname><given-names>S</given-names></name>
<name><surname>Dorranian</surname><given-names>D</given-names></name>
<name><surname>Razavi</surname><given-names>AE</given-names></name>
<name><surname>Naderi</surname><given-names>GA</given-names></name>
<name><surname>Boshtam</surname><given-names>M</given-names></name>
<name><surname>Ghorannevis</surname><given-names>M</given-names></name>
</person-group><article-title>Evaluation of the effects of weak and moderate static magnetic fields on the characteristics of human low density lipoprotein in vitro</article-title><source>Bioelectromagnetics</source><year>2013</year><volume>34</volume><issue>5</issue><fpage>397</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">23361580</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Labreche</surname><given-names>F</given-names></name>
<name><surname>Goldberg</surname><given-names>MS</given-names></name>
<name><surname>Valois</surname><given-names>MF</given-names></name>
<name><surname>Nadon</surname><given-names>L</given-names></name>
<name><surname>Richardson</surname><given-names>L</given-names></name>
<name><surname>Lakhani</surname><given-names>R</given-names></name>
<etal/>
</person-group><article-title>Occupational exposures to extremely low frequency magnetic fields and postmenopausal breast cancer</article-title><source>Am J Ind Med</source><year>2003</year><volume>44</volume><issue>6</issue><fpage>643</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">14635241</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sch&#x000fc;z</surname><given-names>J</given-names></name>
<name><surname>Ahlbom</surname><given-names>A</given-names></name>
</person-group><article-title>Exposure to electromagnetic fields and the risk of childhood leukaemia: a review</article-title><source>Radiat Prot Dosim</source><year>2008</year><volume>132</volume><issue>2</issue><fpage>202</fpage><lpage>211</lpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>Y</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Yao</surname><given-names>A</given-names></name>
<name><surname>Xu</surname><given-names>Z</given-names></name>
<name><surname>Dou</surname><given-names>H</given-names></name>
<name><surname>Shen</surname><given-names>S</given-names></name>
<etal/>
</person-group><article-title>Low frequency magnetic fields induce autophagy-associated cell death in lung cancer through miR-486-mediated inhibition of Akt/mTOR signaling pathway</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">28127051</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saliev</surname><given-names>T</given-names></name>
<name><surname>Begimbetova</surname><given-names>D</given-names></name>
<name><surname>Masoud</surname><given-names>AR</given-names></name>
<name><surname>Matkarimov</surname><given-names>B</given-names></name>
</person-group><article-title>Biological effects of non-ionizing electromagnetic fields: two sides of a coin</article-title><source>Prog Biophys Mol Biol</source><year>2019</year><volume>141</volume><fpage>25</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">30030071</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abdi</surname><given-names>S</given-names></name>
<name><surname>Dorranian</surname><given-names>D</given-names></name>
<name><surname>Naderi</surname><given-names>GA</given-names></name>
<name><surname>Razavi</surname><given-names>AE</given-names></name>
</person-group><article-title>Changes in physicochemical charachteristics of human low density lipoprotein nanoparticles by electromagnetic field exposure</article-title><source>Stud U Babes-Bol Che</source><year>2016</year><volume>61</volume><issue>1</issue><fpage>185</fpage><lpage>197</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grassi</surname><given-names>C</given-names></name>
<name><surname>D&#x02019;Ascenzo</surname><given-names>M</given-names></name>
<name><surname>Torsello</surname><given-names>A</given-names></name>
<name><surname>Martinotti</surname><given-names>G</given-names></name>
<name><surname>Wolf</surname><given-names>F</given-names></name>
<name><surname>Cittadini</surname><given-names>A</given-names></name>
<etal/>
</person-group><article-title>Effects of 50 Hz electromagnetic fields on voltage-gated Ca2+ channels and their role in modulation of neuroendocrine cell proliferation and death</article-title><source>Cell Calcium</source><year>2004</year><volume>35</volume><issue>4</issue><fpage>307</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">15036948</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Phillips</surname><given-names>JL</given-names></name>
</person-group><article-title>Effects of electromagnetic field exposure on gene transcription</article-title><source>J Cell Biochem</source><year>1993</year><volume>51</volume><issue>4</issue><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">8496241</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vadala</surname><given-names>M</given-names></name>
<name><surname>Vallelunga</surname><given-names>A</given-names></name>
<name><surname>Palmieri</surname><given-names>L</given-names></name>
<name><surname>Palmieri</surname><given-names>B</given-names></name>
<name><surname>Morales-Medina J</surname><given-names>C</given-names></name>
<name><surname>Iannitti</surname><given-names>T</given-names></name>
</person-group><article-title>Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson&#x02019;s disease</article-title><source>Behav Brain Funct</source><year>2015</year><volume>11</volume><fpage>26</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">26347217</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crocetti</surname><given-names>S</given-names></name>
<name><surname>Beyer</surname><given-names>C</given-names></name>
<name><surname>Schade</surname><given-names>G</given-names></name>
<name><surname>Egli</surname><given-names>M</given-names></name>
<name><surname>Frohlich</surname><given-names>J</given-names></name>
<name><surname>Franco-Obregon</surname><given-names>A</given-names></name>
</person-group><article-title>Low intensity and frequency pulsed electromagnetic fields selectively impair breast cancer cell viability</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e72944</fpage><lpage>e72944</lpage><pub-id pub-id-type="pmid">24039828</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Petroulakis</surname><given-names>E</given-names></name>
<name><surname>Mamane</surname><given-names>Y</given-names></name>
<name><surname>Le Bacquer</surname><given-names>O</given-names></name>
<name><surname>Shahbazian</surname><given-names>D</given-names></name>
<name><surname>Sonenberg</surname><given-names>N</given-names></name>
</person-group><article-title>mTOR signaling: implications for cancer and anticancer therapy</article-title><source>Br J Cancer</source><year>2006</year><volume>94</volume><issue>2</issue><fpage>195</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">16404421</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wullschleger</surname><given-names>S</given-names></name>
<name><surname>Loewith</surname><given-names>R</given-names></name>
<name><surname>Hall</surname><given-names>MN</given-names></name>
</person-group><article-title>TOR signaling in growth and metabolism</article-title><source>Cell</source><year>2006</year><volume>124</volume><issue>3</issue><fpage>471</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">16469695</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patel</surname><given-names>PH</given-names></name>
<name><surname>Chadalavada</surname><given-names>RS</given-names></name>
<name><surname>Chaganti</surname><given-names>R</given-names></name>
<name><surname>Motzer</surname><given-names>RJ</given-names></name>
</person-group><article-title>Targeting von Hippel-Lindau pathway in renal cell carcinoma</article-title><source>Clin Cancer Res</source><year>2006</year><volume>12</volume><issue>24</issue><fpage>7215</fpage><lpage>7220</lpage><pub-id pub-id-type="pmid">17189392</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>G</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Chen</surname><given-names>Y</given-names></name>
<name><surname>Wang</surname><given-names>X</given-names></name>
<name><surname>Pan</surname><given-names>J</given-names></name>
<name><surname>Li</surname><given-names>G</given-names></name>
<etal/>
</person-group><article-title>Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer</article-title><source>Clin Cancer Res</source><year>2009</year><volume>15</volume><issue>5</issue><fpage>1821</fpage><lpage>1829</lpage><pub-id pub-id-type="pmid">19223493</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Memczak</surname><given-names>S</given-names></name>
<name><surname>Jens</surname><given-names>M</given-names></name>
<name><surname>Elefsinioti</surname><given-names>A</given-names></name>
<name><surname>Torti</surname><given-names>F</given-names></name>
<name><surname>Krueger</surname><given-names>J</given-names></name>
<name><surname>Rybak</surname><given-names>A</given-names></name>
<etal/>
</person-group><article-title>Circular RNAs are a large class of animal RNAs with regulatory potency</article-title><source>Nature</source><year>2013</year><volume>495</volume><issue>7441</issue><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">23446348</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hentze</surname><given-names>MW</given-names></name>
<name><surname>Preiss</surname><given-names>T</given-names></name>
</person-group><article-title>Circular RNAs: splicing&#x02019;s enigma variations</article-title><source>EMBO J</source><year>2013</year><volume>32</volume><issue>7</issue><fpage>923</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">23463100</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qu</surname><given-names>S</given-names></name>
<name><surname>Yang</surname><given-names>X</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Gao</surname><given-names>Y</given-names></name>
<name><surname>Shang</surname><given-names>R</given-names></name>
<etal/>
</person-group><article-title>Circular RNA: a new star of noncoding RNAs</article-title><source>Cancer Lett</source><year>2015</year><volume>365</volume><issue>2</issue><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">26052092</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>S</given-names></name>
<name><surname>Guo</surname><given-names>C</given-names></name>
<name><surname>Zhang</surname><given-names>W</given-names></name>
<name><surname>Che</surname><given-names>W</given-names></name>
<name><surname>Zhang</surname><given-names>J</given-names></name>
<name><surname>Zhuang</surname><given-names>S</given-names></name>
<etal/>
</person-group><article-title>The integrative regulatory network of circRNA, microRNA and mRNA in atrial fibrillation</article-title><source>Front Genet</source><year>2019</year><volume>10</volume><fpage>526</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">31249590</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>X-Y</given-names></name>
<name><surname>Huang</surname><given-names>Z-L</given-names></name>
<name><surname>Xu</surname><given-names>Y-H</given-names></name>
<name><surname>Zheng</surname><given-names>Q</given-names></name>
<name><surname>Chen</surname><given-names>Z</given-names></name>
<name><surname>Song</surname><given-names>W</given-names></name>
<etal/>
</person-group><article-title>Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">28127051</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mansoury</surname><given-names>F</given-names></name>
<name><surname>Babaei</surname><given-names>N</given-names></name>
<name><surname>Abdi</surname><given-names>S</given-names></name>
<name><surname>Entezari</surname><given-names>M</given-names></name>
<name><surname>Doosti</surname><given-names>A</given-names></name>
</person-group><article-title>Changes in NOTCH1 gene and its regulatory circRNA, hsa_circ_0005986 expression pattern in human gastric adenocarcinoma and human normal fibroblast cell line following the exposure to extremely low frequency magnetic field</article-title><source>Electromagn Biol Med</source><year>2021</year><volume>40</volume><issue>3</issue><fpage>375</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">33620018</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bahar</surname><given-names>M</given-names></name>
<name><surname>Majd</surname><given-names>A</given-names></name>
<name><surname>Abdi</surname><given-names>S</given-names></name>
</person-group><article-title>Effects of (ELF) extremely low frequency (50 Hz) AC and DC magnetic fields on lentil germination and seedlings growth</article-title><source>J Theor Appl Phys</source><year>2009</year><volume>3</volume><issue>2</issue><fpage>12</fpage><lpage>16</lpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><collab>Mehrara Sh, Mohammadpour H, Miri SR, Abdi S</collab><article-title>Plasmacytoma variant translocation 1 and nicotinamide phosphoribosyl-transferase long noncoding RNAs promote colorectal cancer</article-title><source>Gene Rep</source><year>2021</year><volume>21</volume><fpage>101</fpage><lpage>113</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Eder</surname><given-names>SH</given-names></name>
<name><surname>Cadiou</surname><given-names>H</given-names></name>
<name><surname>Muhamad</surname><given-names>A</given-names></name>
<name><surname>McNaughton</surname><given-names>PA</given-names></name>
<name><surname>Kirschvink</surname><given-names>JL</given-names></name>
<name><surname>Winklhofer</surname><given-names>M</given-names></name>
</person-group><article-title>Magnetic characterization of isolated candidate vertebrate magnetoreceptor cells</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><issue>30</issue><fpage>12022</fpage><lpage>12027</lpage><pub-id pub-id-type="pmid">22778440</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zimmerman</surname><given-names>JW</given-names></name>
<name><surname>Pennison</surname><given-names>MJ</given-names></name>
<name><surname>Brezovich</surname><given-names>I</given-names></name>
<name><surname>Yi</surname><given-names>N</given-names></name>
<name><surname>Yang</surname><given-names>CT</given-names></name>
<name><surname>Ramaker</surname><given-names>R</given-names></name>
<etal/>
</person-group><article-title>Cancer cell proliferation is inhibited by specific modulation frequencies</article-title><source>Br J Cancer</source><year>2012</year><volume>106</volume><issue>2</issue><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">22134506</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ashdown</surname><given-names>CP</given-names></name>
<name><surname>Johns</surname><given-names>SC</given-names></name>
<name><surname>Aminov</surname><given-names>E</given-names></name>
<name><surname>Unanian</surname><given-names>M</given-names></name>
<name><surname>Connacher</surname><given-names>W</given-names></name>
<name><surname>Friend</surname><given-names>J</given-names></name>
<etal/>
</person-group><article-title>Pulsed low-frequency magnetic fields induce tumor membrane disruption and altered cell viability</article-title><source>Biophys J</source><year>2020</year><volume>118</volume><issue>7</issue><fpage>1552</fpage><lpage>1563</lpage><pub-id pub-id-type="pmid">32142642</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crocetti</surname><given-names>S</given-names></name>
<name><surname>Beyer</surname><given-names>C</given-names></name>
<name><surname>Schade</surname><given-names>G</given-names></name>
<name><surname>Egli</surname><given-names>M</given-names></name>
<name><surname>Fr&#x000f6;hlich</surname><given-names>J</given-names></name>
<name><surname>Franco-Obreg&#x000f3;n</surname><given-names>A</given-names></name>
</person-group><article-title>Low intensity and frequency pulsed electromagnetic fields selectively impair breast cancer cell viability</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>9</issue><fpage>e72944</fpage><lpage>e72944</lpage><pub-id pub-id-type="pmid">24039828</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pessina</surname><given-names>G</given-names></name>
<name><surname>Aldinucci</surname><given-names>C</given-names></name>
<name><surname>Palmi</surname><given-names>M</given-names></name>
<name><surname>Sgaragli</surname><given-names>G</given-names></name>
<name><surname>Benocci</surname><given-names>A</given-names></name>
<name><surname>Meini</surname><given-names>A</given-names></name>
<etal/>
</person-group><article-title>Pulsed electromagnetic fields affect the intracellular calcium concentrations in human astrocytoma cells</article-title><source>Bioelectromagnetics</source><year>2001</year><volume>22</volume><issue>7</issue><fpage>503</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">11568936</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sulpizio</surname><given-names>M</given-names></name>
<name><surname>Falone</surname><given-names>S</given-names></name>
<name><surname>Amicarelli</surname><given-names>F</given-names></name>
<name><surname>Marchisio</surname><given-names>M</given-names></name>
<name><surname>Di Giuseppe</surname><given-names>F</given-names></name>
<name><surname>Eleuterio</surname><given-names>E</given-names></name>
<etal/>
</person-group><article-title>Molecular basis underlying the biological effects elicited by extremely low-frequency magnetic field (ELF-MF) on neuroblastoma cells</article-title><source>J Cell Biochem</source><year>2011</year><volume>112</volume><issue>12</issue><fpage>3797</fpage><lpage>3806</lpage><pub-id pub-id-type="pmid">21826706</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Trillo</surname><given-names>M&#x000c1;</given-names></name>
<name><surname>Mart&#x000ed;nez</surname><given-names>MA</given-names></name>
<name><surname>Cid</surname><given-names>MA</given-names></name>
<name><surname>Leal</surname><given-names>J</given-names></name>
<name><surname>&#x000da;beda</surname><given-names>A</given-names></name>
</person-group><article-title>Influence of a 50 Hz magnetic field and of all-trans&#x02011;retinol on the proliferation of human cancer cell lines</article-title><source>Int J Oncol</source><year>2012</year><volume>40</volume><issue>5</issue><fpage>1405</fpage><lpage>1413</lpage><pub-id pub-id-type="pmid">22293994</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mart&#x000ed;nez</surname><given-names>MA</given-names></name>
<name><surname>&#x000da;beda</surname><given-names>A</given-names></name>
<name><surname>Cid</surname><given-names>MA</given-names></name>
<name><surname>Trillo</surname><given-names>M&#x000c1;</given-names></name>
</person-group><article-title>The proliferative response of NB69 human neuroblastoma cells to a 50 Hz magnetic field is mediated by ERK1/2 signaling</article-title><source>Cell Physiol Biochem</source><year>2012</year><volume>29</volume><issue>5-6</issue><fpage>675</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">22613968</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>CY</given-names></name>
<name><surname>Chang</surname><given-names>CW</given-names></name>
<name><surname>Chen</surname><given-names>CR</given-names></name>
<name><surname>Chuang</surname><given-names>CY</given-names></name>
<name><surname>Chiang</surname><given-names>C-S</given-names></name>
<name><surname>Shu</surname><given-names>WY</given-names></name>
<etal/>
</person-group><article-title>Extremely low-frequency electromagnetic fields cause G1 phase arrest through the activation of the ATM-Chk2-p21 pathway</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>8</issue><fpage>e104732</fpage><lpage>e104732</lpage><pub-id pub-id-type="pmid">25111195</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jung</surname><given-names>IS</given-names></name>
<name><surname>Kim</surname><given-names>HJ</given-names></name>
<name><surname>Noh</surname><given-names>R</given-names></name>
<name><surname>Kim</surname><given-names>SC</given-names></name>
<name><surname>Kim</surname><given-names>CW</given-names></name>
</person-group><article-title>Effects of extremely low frequency magnetic fields on NGF induced neuronal differentiation of PC12 cells</article-title><source>Bioelectromagnetics</source><year>2014</year><volume>35</volume><issue>7</issue><fpage>459</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">25159695</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Litovitz</surname><given-names>T</given-names></name>
<name><surname>Montrose</surname><given-names>C</given-names></name>
<name><surname>Wang</surname><given-names>W</given-names></name>
</person-group><article-title>Dose-response implications of the transient nature of electromagnetic-field-induced bioeffects: Theoretical hypotheses and predictions</article-title><source>Bioelectromagnetics</source><year>1992</year><volume>13</volume><issue>S1</issue><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">1317177</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feng</surname><given-names>B</given-names></name>
<name><surname>Ye</surname><given-names>C</given-names></name>
<name><surname>Qiu</surname><given-names>L</given-names></name>
<name><surname>Chen</surname><given-names>L</given-names></name>
<name><surname>Fu</surname><given-names>Y</given-names></name>
<name><surname>Sun</surname><given-names>W</given-names></name>
</person-group><article-title>Mitochondrial ROS release and subsequent Akt activation potentially mediated the anti-apoptotic effect of a magnetic field on FL cell</article-title><source>Cell Physiol Biochem</source><year>2016</year><volume>38</volume><issue>6</issue><fpage>2489</fpage><lpage>2499</lpage><pub-id pub-id-type="pmid">27310130</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Robison</surname><given-names>JG</given-names></name>
<name><surname>Pendleton</surname><given-names>AR</given-names></name>
<name><surname>Monson</surname><given-names>KO</given-names></name>
<name><surname>Murray</surname><given-names>BK</given-names></name>
<name><surname>O&#x02019;Neill</surname><given-names>KL</given-names></name>
</person-group><article-title>Decreased DNA repair rates and protection from heat induced apoptosis mediated by electromagnetic field exposure</article-title><source>Bioelectromagnetics</source><year>2002</year><volume>23</volume><issue>2</issue><fpage>106</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">11835257</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chiang</surname><given-names>GG</given-names></name>
<name><surname>Abraham</surname><given-names>RT</given-names></name>
</person-group><article-title>Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><issue>27</issue><fpage>25485</fpage><lpage>25490</lpage><pub-id pub-id-type="pmid">15899889</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>XY</given-names></name>
<name><surname>Huang</surname><given-names>ZL</given-names></name>
<name><surname>Zhang</surname><given-names>PB</given-names></name>
<name><surname>Huang</surname><given-names>XY</given-names></name>
<name><surname>Huang</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>HC</given-names></name>
<etal/>
</person-group><article-title>CircRNA-100338 is associated with mTOR signaling pathway and poor prognosis in hepatocellular carcinoma</article-title><source>Front Oncol</source><year>2019</year><volume>9</volume><fpage>392</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">31157168</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Panagopoulos</surname><given-names>D</given-names></name>
</person-group><article-title>J, Karabarbounis A, Margaritis LH.Mechanism for action of electromagnetic fields on cells</article-title><source>Biochem Biophys Res Commun</source><year>2002</year><volume>298</volume><issue>1</issue><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">12379225</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Consales</surname><given-names>C</given-names></name>
<name><surname>Merla</surname><given-names>C</given-names></name>
<name><surname>Marino</surname><given-names>C</given-names></name>
<name><surname>Benassi</surname><given-names>B</given-names></name>
</person-group><source>Electromagnetic fields, oxidative stress, and neurodegeneration.Int J Cell Biol</source><publisher-name>Int J Cell Biol</publisher-name><year>2012</year><fpage>1</fpage><lpage>17</lpage></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mihai</surname><given-names>CT</given-names></name>
<name><surname>Rotinberg</surname><given-names>P</given-names></name>
<name><surname>Brinza</surname><given-names>F</given-names></name>
<name><surname>Vochita</surname><given-names>G</given-names></name>
</person-group><article-title>Extremely low-frequency electromagnetic fields cause DNA strand breaks in normal cells</article-title><source>J Environ Health Sci Eng</source><year>2014</year><volume>12</volume><issue>1</issue><fpage>15</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">24401758</pub-id></element-citation></ref></ref-list></back></article>
